Ondine reports successful food pathogen study
ONDINE BIOMEDICAL INC.
("Ondine Biomedical", "Ondine" or the "Company")
Ondine Biomedical reports photodisinfection is highly effective against key food-borne pathogens
· Photodisinfection achieved complete elimination (>99.999% kill) against Salmonella enterica and 99.999% reduction of MRSA biofilm - exceeding food safety requirements
· Successful program made possible by Government of Canada and Canadian Agricultural Partnership's AgriScience Program.
Ondine Biomedical (OBI:LON), a Canadian life sciences company, reported that photodisinfection being developed for food processing demonstrated high efficacy against key food-borne pathogens. Results of the proof-of-concept study, presented on 12 April, 2023,[1] confirmed 4-5 log (up to 99.999%) elimination of pathogens commonly found on hard surfaces in meat processing facilities, as well as those directly located on fresh-cut chicken, beef, and pork meat - paving the way for Canadian leadership in food safety innovations. On the basis of these findings, Ondine intends to apply for additional non-dilutive funding to continue the development of food-safe photodisinfection technology.
Bacterial contamination in the meat industry significantly impacts consumers, workers, animals, community well-being, and industry profitability. Consuming meat contaminated with harmful bacteria can cause illness and death, with over 400,000 people globally dying each year from eating contaminated food.[2] This damages public health and leads to loss of consumer confidence in meat products which can significantly impact profitability across the meat industry.
Conducted in collaboration with Chinook Contract Research, the Ondine Biomedical program identified four food-safe photosensitizers - compounds which eliminate pathogens when exposed to a specific wavelength of light. The photosensitizers were screened against the bacterial organisms Salmonella enterica (Salmonella) and MRSA (Methicillin-resistant Staphylococcus aureus), grown and tested as biofilms. Biofilms are known to tolerate up to 1000 times higher concentrations of antibiotics and disinfectants than planktonic (free-floating) cells, which are typically used in food safety studies.[3] Results showed that the photodisinfection process was able to achieve complete elimination of all Salmonella enterica biofilms (>99.999%), and a 99.999% (5-log) reduction of MRSA biofilms in several different food safety models.[4]
This research was funded in part by the Government of Canada under the Canadian Agricultural Partnership's AgriScience Program, a federal, provincial, territorial initiative.[5] The AgriScience Program aims to accelerate the pace of innovation by providing funding and support for pre-commercial science activities and cutting-edge research that benefits consumers and the agriculture and agri-food sector.
Dr. Joe Ross, Senior Scientist at Chinook Contract Research, said:
"For our optimized photosensitized light combinations against MRSA we were seeing upwards of 5-log10 reduction, 99.999% order reduction, as well as maximum kill of Salmonella enterica, meaning that we could not detect any of the biofilm after photodisinfection. These results show that photodisinfection is already in the same ballpark for efficacy as chemical disinfectants like bleach or hydrogen peroxide, and it is meeting the minimum reduction thresholds for both food and non-food contact surfaces."
There is a significant need in the food-processing industry for new technologies to reduce the incidence of food-borne pathogens - bacteria, fungi, viruses, and protozoa. Eradicating these invasive microbes will help protect the consumers, workers and animals within the $9.4 billion (2021) Canadian meat export industry, as well as reduce the incidence of food-borne illnesses. Photodisinfection is particularly suitable for the food processing industry because it is non-antibiotic and broad-spectrum, meaning that it could be widely adopted without risking increased antimicrobial resistance.
S. enterica , a subspecies of Salmonella, is a leading cause of human infections from the consumption of contaminated food. Globally, it is estimated to cause 93.8 million human infections and 155,000 deaths annually, and accounts for 38% of foodborne illnesses, 35% of hospitalizations and 28% of deaths due to foodborne illnesses worldwide.[6] A Centers for Disease Control and Prevention (CDC) study published in 2021 showed an estimated 40% increase in antibiotic-resistant Salmonella infections across the US from 2004 to 2016.[7]
Dr. Richard Rusk (DVM, MD, CCFP, MPH, DipZBPV, FRSPH), Prevention Medicine Specialist and former Manitoba Medical Officer of Health, said:
"I believe that photodisinfection is an innovative and very important technology when it comes to food safety. We have around 10% wastage of meat in Canada each year due to contamination, so we need to continue to improve food safety and reduce meat contamination. This new approach to eradicating pathogens is also increasingly vital in light of growing concerns over antibiotic use, antimicrobial stewardship and resistance. By 2050, antimicrobial resistance will have more of an impact on human life expectancy than cancer, so improving the interaction between food safety, workers' health, and animals in the food chain is key."
**ENDS**
|
Ondine Biomedical Inc. |
|
|
Angelika Vance, Corporate Communications |
+001 (604) 838 2702 |
|
|
|
|
Singer Capital Markets (Nominated Adviser and Joint Broker) |
|
|
Aubrey Powell, Asha Chotai, Sam Butcher |
+44 (0)20 7496 3000 |
|
|
|
|
RBC Capital Markets (Joint Broker) |
|
|
Rupert Walford, Kathryn Deegan |
+44 (0)20 7653 4000 |
|
|
|
|
Vane Percy & Roberts (Media Contact) |
|
|
Simon Vane Percy, Amanda Bernard |
+44 (0)77 1000 5910 |
Microbial foodborne disease
Foodborne illnesses are a major public health concern due to the high risk of microbial contamination of food. In 2010, more than 580 million illnesses and 351,000 deaths worldwide were associated with food contaminated by enteric pathogens according to a World Health Organization (WHO) estimate. Meat and meat-based products are particularly prone to contamination, accounting for more than 16% of total foodborne outbreaks in Europe in 2016.
One of the most significant consequences of bacterial contamination in the meat industry is the cost associated with food recalls. When a meat product is found to be contaminated, the meat must be recalled from the market, which can be a costly and time-consuming process. This can have a detrimental effect on the meat industry, as the cost of recalling meat products and the potential loss of revenue can be substantial.
Meat processors must ensure they have appropriate sanitation procedures in place to help prevent bacterial growth. This includes regularly cleaning and disinfecting equipment and facilities, ensuring employees follow proper hygiene protocols, utilizing appropriate food safety measures such as adequate packaging and refrigeration, and conducting routine testing for harmful bacteria. Worker safety in light of antimicrobial resistance is a growing concern for the industry.
Source: Int. J. Environ. Res. Public Health 2020, 17, 688; doi:10.3390/ijerph17030688
About Ondine Biomedical Inc.
Ondine Biomedical Inc. is a Canadian headquartered company innovating in the field of photodisinfection therapies. Ondine has a pipeline of investigational products, based on its proprietary photodisinfection platform, in various stages of development. Products beyond nasal photodisinfection include therapies for a variety of medical indications such as chronic sinusitis, ventilator-associated pneumonia, burns, and other indications.
[1] https://ondinebio.com/media/webinar-photodisinfection-for-food-safety/
[4] >5 log10 CFU (colony forming units) reduction
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 day ago Savannah Energy
- 1 day ago Buccaneer Energy PLC
- 1 day ago Savannah Energy
- 1 day ago Carclo
- 1 day ago Schroder Japan Growth Fund